Научные публикации про COVID-19 за неделю (с 21 по 27 ноября)

В этот раз 49 публикаций из научных журналов с высоким импакт-фактором.

Содержание:

— Последствия COVID-19
— Вакцины и омикрон
— Вакцины: группы риска
— Вакцины: нежелательные явления
— Вакцины: новые разработки
— Иммунитет
— Профилактика
— Группы риска
— Течение COVID-19
— Поведение
— Последствия пандемии
— Геномика и другое

Сказать спасибо за работу: 5536 9138 3126 6560

Последствия COVID-19

• Association of COVID-19 with diabetes: a systematic review and meta-analysis https://www.nature.com/articles/s41598-022-24185-7 (article, 23.11.22)
• Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer’s disease individuals https://www.biorxiv.org/content/10.1101/2022.11.23.517706v1 (preprint, 23.11.22)

Вакцины и омикрон

• Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years https://www.nature.com/articles/s41598-022-24409-w (article, 27.11.22)
• Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory https://www.nature.com/articles/s41598-022-24938-4 (article, 27.11.22)
• SARS-CoV-2 Vaccine Strain Selection: Guidance from Influenza https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac454/6845837 (manuscript, 25.11.22)
• Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00729-0/fulltext (article, 24.11.22)
  +
  Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00759-9/fulltext (comment, 24.11.22)
• Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination https://www.nejm.org/doi/full/10.1056/NEJMc2212772 (correspondence, 23.11.22)
• SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children https://www.science.org/doi/10.1126/scitranslmed.abn9237 (article, 23.11.22)
• Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 – VISION Network, August 2021 – March 2022 https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac458/6841302 (manuscript, 23.11.22)
• Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004037 (article, 22.11.22)

Вакцины: группы риска

• Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfac307/6845751 (manuscript, 24.11.22)
• Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keac661/6839954 (manuscript, 22.11.22)
• Factors associated with vaccine-induced T cell immune responses against SARS-CoV-2 in kidney transplant recipients https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac449/6835057 (manuscript, 21.11.22)

Вакцины: нежелательные явления

• Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens https://www.ijidonline.com/article/S1201-9712(22)00614-2/fulltext (article, 21.11.22)
• Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study https://www.cmaj.ca/content/194/45/E1529 (article, 21.11.22)

Вакцины: новые разработки

• Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses https://www.science.org/doi/10.1126/science.abo2523 (article, 25.11.22)
• Mucosal IgA against SARS-CoV-2 Omicron Infection https://www.nejm.org/doi/full/10.1056/NEJMc2213153 (correspondence, 24.11.22)
• Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial https://jamanetwork.com/journals/jama/fullarticle/2798745 (clinical trials update, 22.11.22)
• Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen https://academic.oup.com/intimm/advance-article/doi/10.1093/intimm/dxac055/6840026 (manuscript, 22.11.22)
• Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2 https://www.nature.com/articles/s41385-022-00578-9 (article, 21.11.22)

Иммунитет

• Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples https://www.nature.com/articles/s41467-022-34638-2 (article, 25.11.22)
• Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity https://www.nature.com/articles/s41467-022-34895-1 (article, 25.11.22)
• Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection https://www.nature.com/articles/s41390-022-02360-w (article, 25.11.22)
• SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions https://www.ijidonline.com/article/S1201-9712(22)00616-6/fulltext (article, 24.11.22)
• Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein https://www.nature.com/articles/s41598-022-24730-4 (article, 22.11.22)
• Bulk IgG Glycosylation Predicts COVID-19 Severity and Vaccine Antibody Response https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01687-4 (article, 21.11.22)

Профилактика

• Lifting Universal Masking in Schools — Covid-19 Incidence among Students and Staff https://www.nejm.org/doi/full/10.1056/NEJMoa2211029 (article, 24.11.22)
  +
  Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19 https://www.nejm.org/doi/full/10.1056/NEJMe2213556 (editorial, 24.11.22)

Группы риска

• Tobacco use and risk of COVID-19 infection in the Finnish general population https://www.nature.com/articles/s41598-022-24148-y (article, 25.11.22)
• Post-traumatic stress disorder and risk for hospitalization and death following COVID-19 infection https://www.nature.com/articles/s41398-022-02156-w (article, 22.11.22)
• The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis https://www.nature.com/articles/s41408-022-00754-x (correspondence, 22.11.22)

Течение COVID-19

• CT-based Pathological Lung Opacities Volume as a Predictor of Critical Illness and Inflammatory Response Severity in Patients with COVID-19 https://www.cell.com/heliyon/fulltext/S2405-8440(22)03196-6 (article, 25.11.22)
• Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients https://www.nature.com/articles/s41598-022-21944-4 (article, 24.11.22)
• The systemic renin-angiotensin system in COVID-19 https://www.nature.com/articles/s41598-022-24628-1 (article, 22.11.22)
• Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac452/6835053 (manuscript, 21.11.22)
• Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality https://www.nature.com/articles/s41598-022-23922-2 (article, 21.11.22)

Поведение

• Understanding and neutralising covid-19 misinformation and disinformation https://www.bmj.com/content/379/bmj-2022-070331 (analysis, 22.11.22)
• Meta-summaries effective for improving awareness and understanding of COVID-19 vaccine safety research https://www.nature.com/articles/s41598-022-24607-6 (article, 21.11.22)
• An epidemic context elicits more prosocial decision-making in an intergroup social dilemma https://www.nature.com/articles/s41598-022-22187-z (article, 21.11.22)

Последствия пандемии

• Late-stage diagnosis for head and neck cancers have increased since the pandemic https://www.nature.com/articles/s41415-022-5296-1 (news, 25.11.22)

Геномика и другое

• Single-cell RNA-sequencing data analysis reveals a highly correlated triphasic transcriptional response to SARS-CoV-2 infection https://www.nature.com/articles/s42003-022-04253-4 (article, 27.11.22)
• CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis https://www.nature.com/articles/s41392-022-01230-5 (article, 25.11.22)
• The free fatty acid–binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron https://www.science.org/doi/10.1126/sciadv.adc9179 (article, 24.11.22)
• Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning https://www.science.org/doi/10.1126/sciadv.add7221 (article, 24.11.22)
• Endosomes, receptors, and viruses https://www.science.org/doi/10.1126/science.adf4469 (essay, 24.11.22)
• Enhanced Neutralization Resistance of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2 https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(22)00568-6 (short article, 21.11.22)
• ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells https://journals.asm.org/doi/10.1128/mbio.02566-22 (article, 21.11.22)
• SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual https://www.medrxiv.org/content/10.1101/2022.11.23.22282673v1 (preprint, 24.11.22)
• Evolution of the SARS-CoV-2 mutational spectrum https://www.biorxiv.org/content/10.1101/2022.11.19.517207v1 (preprint, 21.11.22)